Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinoids and interferon: a new promising combination?

W Bollag1

  • 1Pharmaceutical Research, F. Hoffmann-La Roche Ltd, Basle, Switzerland.

British Journal of Haematology
|October 1, 1991
PubMed
Summary

Retinoids and interferon alpha show promise in cancer treatment. Combining retinoids with cytokines like interferon alpha potentiates their differentiation-inducing effects, suggesting a potent therapeutic strategy for neoplastic diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The enhancement of the after effect of ionizing radiation by a cytotoxic methylhydrazine derivative. 1966.

European journal of cancer (Oxford, England : 1990)·2004
Same author

Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines.

Anticancer research·2000
Same author

Successful treatment of chronic hand eczema with oral 9-cis-retinoic acid.

Dermatology (Basel, Switzerland)·2000
Same author

Calcitriol enhances antineoplastic and antiangiogenic effects of interleukin-12.

Archives of dermatological research·1999
Same author

RARalpha antagonist Ro 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines.

International journal of cancer·1998
Same author

Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.

Anticancer research·1998

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Retinoids, including tretinoin and isotretinoin, exhibit preventive and therapeutic effects against chemically-induced tumors.
  • Clinical applications of retinoids in various cancers show variable effectiveness, with monotherapy often being unsatisfactory.
  • Interferon alpha (IFN alpha) monotherapy is effective only for specific oncological indications.

Purpose of the Study:

  • To investigate the combined effects of retinoids and cytokines, specifically interferon alpha, on cancer cell differentiation.
  • To evaluate the potential of retinoid-cytokine combinations as a therapeutic strategy for neoplastic diseases.

Main Methods:

  • Experiments were conducted using transformed cell lines, including HL-60 (acute promyelocytic leukemia).
  • Differentiation was assessed by the induction of an oxidative burst potential.
  • The study compared the differentiation-inducing activity of various retinoids and the potentiation effects of different cytokines.

Main Results:

  • Retinoids demonstrated varying differentiation-inducing activity: tretinoin > isotretinoin > acitretin.
  • Cytokines alone had no differentiation-inducing effect.
  • Interferon alpha (IFN alpha), IFN beta, IFN gamma, TNF alpha, G-CSF, IL-1 alpha, and IL-4 significantly potentiated retinoid-induced differentiation in HL-60 and other cell lines. IFN alpha showed marked potentiation.

Conclusions:

  • The combination of retinoids with certain cytokines, particularly IFN alpha, enhances differentiation induction.
  • This synergistic effect, combining retinoid antiproliferative/differentiation properties with IFN alpha's effects, suggests a promising therapeutic approach for neoplastic diseases.

Related Experiment Videos